Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3

[1]  Lin He,et al.  Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome. , 2010, Molecular genetics and metabolism.

[2]  Annette Lee,et al.  Genome-wide association study in alopecia areata implicates both innate and adaptive immunity , 2010, Nature.

[3]  Shuhua Xu,et al.  Genomic dissection of population substructure of Han Chinese and its implication in association studies. , 2009, American journal of human genetics.

[4]  Cheng Hu,et al.  PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 Are Associated with Type 2 Diabetes in a Chinese Population , 2009, PloS one.

[5]  A. Hofman,et al.  Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. , 2009, Human reproduction.

[6]  Li Li,et al.  PCR/LDR/capillary electrophoresis for detection of single‐nucleotide differences between fetal and maternal DNA in maternal plasma , 2009, Prenatal diagnosis.

[7]  E. Diamanti-Kandarakis,et al.  Metabolic syndrome and polycystic ovary syndrome... and vice versa. , 2009, Arquivos brasileiros de endocrinologia e metabologia.

[8]  E. Carmina.  Cardiovascular risk and events in polycystic ovary syndrome , 2009, Climacteric : the journal of the International Menopause Society.

[9]  R. Corcoy,et al.  Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome , 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[10]  P. Zhang,et al.  Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women. , 2008, Fertility and sterility.

[11]  Joshua M. Korn,et al.  Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs , 2008, Nature Genetics.

[12]  M. McCarthy,et al.  Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.

[13]  S. Dwivedi,et al.  Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[14]  Zi-jiang Chen,et al.  Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. , 2007, Neuro endocrinology letters.

[15]  B. Zahorska-Markiewicz,et al.  Is the polycystic ovary syndrome associated with chronic inflammation per se? , 2007, European journal of obstetrics, gynecology, and reproductive biology.

[16]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[17]  J. Bullerdiek,et al.  Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin. , 2006, Thyroid : official journal of the American Thyroid Association.

[18]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[19]  M. Goodarzi,et al.  Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. , 2006, Best practice & research. Clinical endocrinology & metabolism.

[20]  Min Huang,et al.  Involvement of ALF in human spermatogenesis and male infertility. , 2006, International journal of molecular medicine.

[21]  Yunxia Cao,et al.  [Microsatellite polymorphism of (tttta) n in the promoter of CYP11a gene in Chinese women with polycystic ovary syndrome]. , 2005, Zhonghua yi xue za zhi.

[22]  Lin He,et al.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci , 2005, Cell Research.

[23]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[24]  P. Moulin,et al.  [Metabolic syndrome and polycystic ovary syndrome]. , 2005, Journees annuelles de diabetologie de l'Hotel-Dieu.

[25]  Yue-ran Zhao,et al.  [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome]. , 2004, Zhonghua fu chan ke za zhi.

[26]  Francis Barany,et al.  Capillary and microelectrophoretic separations of ligase detection reaction products produced from low‐abundant point mutations in genomic DNA , 2004, Electrophoresis.

[27]  C. Carlson,et al.  Mapping complex disease loci in whole-genome association studies , 2004, Nature.

[28]  Carol A. Miller,et al.  Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[30]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[31]  S. Sudo,et al.  Genetic and functional analyses of polymorphisms in the human FSH receptor gene. , 2002, Molecular human reproduction.

[32]  J. L. San Millán,et al.  The -597 G-->A and -174 G-->C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. , 2002, The Journal of clinical endocrinology and metabolism.

[33]  S. Ng,et al.  Absence of Mutations in the Coding Regions of Follicle-Stimulating Hormone Receptor Gene in Singapore Chinese Women with Premature Ovarian Failure and Polycystic Ovary Syndrome , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[34]  J. Radziuk,et al.  Insulin sensitivity and its measurement: structural commonalities among the methods. , 2000, The Journal of clinical endocrinology and metabolism.

[35]  A. Latronico,et al.  The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary–gonadal axis in both sexes , 2000, Clinical endocrinology.

[36]  P. McKeigue,et al.  Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study , 2000, Human fertility.

[37]  M. Cavaghan,et al.  Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. , 1999, Diabetes care.

[38]  A. Latronico,et al.  A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. , 1998, Molecular endocrinology.

[39]  H. Brunner,et al.  An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. , 1996, The Journal of clinical endocrinology and metabolism.

[40]  D. Ferriman,et al.  Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.

[41]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.